Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SILO

Silo Pharma (QB) (SILO)

Silo Pharma Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:SILO
DateTimeSourceHeadlineSymbolCompany
06/29/20234:32PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
05/26/20234:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
05/18/20234:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
02/15/20234:17PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
02/14/20234:01PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SILOSilo Pharma Inc (QB)
02/03/20238:01AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
01/31/20234:16PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
01/20/20238:01AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
12/15/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
12/01/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
11/10/20224:49PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
10/18/20225:16PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
09/30/20228:46AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
09/28/20224:35PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:SILOSilo Pharma Inc (QB)
09/27/20228:30AMEdgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)USOTC:SILOSilo Pharma Inc (QB)
09/27/20226:03AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:SILOSilo Pharma Inc (QB)
09/26/20224:01PMEdgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)USOTC:SILOSilo Pharma Inc (QB)
09/09/20226:01AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
08/29/20226:17AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
08/01/20224:02PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
07/25/20227:13AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
06/21/20228:05AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
05/13/20224:19PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
03/11/20224:04PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
03/07/20225:26PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:SILOSilo Pharma Inc (QB)
02/14/20225:43PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:SILOSilo Pharma Inc (QB)
01/05/20226:19PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:SILOSilo Pharma Inc (QB)
12/15/20211:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
11/10/20215:15PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
10/27/20214:31PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
 Showing the most relevant articles for your search:USOTC:SILO